Form 4: TG Therapeutics Director Laurence Charney Donates Shares to Charity
SEC Form 4 Filing
Director Laurence N. Charney of TG Therapeutics, Inc. reports a donation of 6,000 common stock shares to a charitable organization.
Summary
- On March 10, 2025, Laurence N. Charney, a director of TG Therapeutics, Inc., donated 6,000 shares of common stock to a 501(c)(3) charitable organization.
- The transaction was reported on a Form 4 filing with the SEC.
- Following the transaction, Charney beneficially owns 201,479 shares of TG Therapeutics common stock, including restricted shares that vest over time.
Sentiment
Score: 6
Explanation: Neutral sentiment as it reports a standard transaction (donation of shares). It doesn't inherently indicate positive or negative performance for the company.
Positives
- A director donating shares to a charitable organization can be viewed positively.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to the market.
Stakeholder Impact
- The donation of shares has a minimal direct impact on stakeholders.
Key Dates
| Date | Description |
|---|---|
| 03/10/2025 | Date of the transaction (donation of shares) |
| 03/11/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.